ASMI welcomes reform bill
This article was originally published in OTC Bulletin & The Rose Sheet
Executive Summary
The Australian Self Medication Industry (ASMI) has welcomed the passing of a package of regulatory measures it claimed would “strengthen protection for consumers”.
You may also be interested in...
Australia Allows More Time For Labeling Compliance Due To COVID-19
The Australian medicines regulators is allowing sponsors of non-prescription drugs to request an additional six months to transition to new labeling requirements that will become mandatory as of September.
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.